AI Classification
PositiveFine-tuned Classification
PositiveA Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis
Cannabinoids for the Treatment of Dermatologic Conditions
Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum
Cannabis and the skin
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis